Funding · Commerce & Consumer Brands

ClayCo raises ₹34.6 crore in Series A

By Startup Enthusiast · 8 April 2026

What they do

ClayCo makes premium skincare products blending ancient beauty rituals with modern science

It raised ₹34.6 crore ($3.7 Mn) in Series A led by Twenty-Nine Capital Partners Ventures

The company grew revenue 14 times from ₹5 crore in FY24 to ₹72 crore in FY26

ClayCo closed a Series A round of Rs 34.59 crore (about $3.7 Mn).
The round was led by Twenty-Nine Capital Partners Ventures.
ICMG Global Ventures II participated in the round.
The company plans to use the funds to accelerate product development and expand into body care and hair care categories.
It will also strengthen working capital and scale supply chain and inventory capabilities.
ClayCo aims to expand brand visibility across D2C (direct-to-consumer) and marketplaces.

India's skincare market is expected to grow from $8.4 Bn in 2024 to $17.1 Bn by 2033.
ClayCo's revenue jumped 14 times from ₹5 crore in FY24 to ₹72 crore in FY26.
The company was featured in Inc42's '30 Startups To Watch' in October 2024.

ClayCo is a premium skincare brand that blends ancient beauty rituals with modern science.
Its debut collection is called 'Rituals of Japan', combining Japanese beauty traditions with Indian skincare.
Products include cleansers, moisturisers, face washes, serums, masks, polishers, glow essences, and sponges.
Bestsellers are the Rice & Sake Mask and Enzyme Scrub.
SKU prices range from ₹600 to ₹1,300.
Sales channels include its own website, Amazon, Nykaa, Myntra, Tira, Zepto, and Blinkit.
The brand's formulation philosophy uses Japanese skincare precision, Korean beauty science, ingredient integrity, skin barrier research, and clinical efficacy.

Accelerate product development and expand into body care and hair care categories.
Strengthen working capital and scale supply chain and inventory capabilities.
Expand brand visibility across D2C and marketplaces.

Twenty-Nine Capital Partners Ventures (lead)
ICMG Global Ventures II (participated) — ICMG Global Ventures II Pte. Ltd., Singapore

Product: Skincare products with natural and science-backed ingredients priced between Rs 600-1,300 per product
Customers: Consumers seeking efficacious, clinically validated premium skincare products with international quality standards
How it makes money: Direct-to-consumer brand selling through D2C platform and marketplaces like Nykaa
What sets it apart: Clinical research and dermatological validation with specialty ingredients like exosomes and retinal, drawing from Japanese and Korean skincare approaches